Scholars Central

Mini reviewPublished 18 Sep 2024

Review of Proliferative Retinopathy in Chronic Myeloid Leukemia (CML)

Authors: Alan Chew Bonilla, Emanuel Chew Bonilla, Paulina Bueno Zarazua, Federico Graue Wiechers

Journal of Blood & Lymph

Volume 14 · Issue 4 · Pages 1–5

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Proliferative retinopathy is a significant ocular complication associated with Chronic Myeloid Leukemia (CML) and other forms of leukemia. Understanding the various ophthalmological manifestations and their management is important for improving patient outcomes. This review aims to provide a comprehensive overview of the ocular alterations seen in leukemia patients, with a particular focus on proliferative retinopathy in CML, its delayed manifestation and management strategies. A thorough literature review was conducted, emphasizing key studies and case reports that highlight the ocular complications of leukemia, particularly those related to proliferative retinopathy in CML. Leukemia can cause a range of ophthalmic manifestations, including retinal hemorrhages, microaneurysms and neovascularization. Proliferative retinopathy, characterized by abnormal neovascularization is more common in chronic leukemias like CML. This condition often presents in the advanced stages of CML and can significantly impair vision if not managed promptly. The pathogenesis involves chronic hypoxia, leukostasis and inflammatory mediators, leading to the formation of fragile new blood vessels. Delayed manifestation of proliferative retinopathy in CML underscores the importance of regular ophthalmological surveillance, even in patients with well-controlled systemic disease. Early detection and timely intervention are essential in managing proliferative retinopathy in CML. A multidisciplinary approach involving both hematologists and ophthalmologists is essential for optimal patient care. Regular follow-up and vigilant screening for ocular changes can significantly improve the prognosis and quality of life for leukemia patients. This review highlights the need for ongoing research and education to better understand and manage the ocular complications of leukemia.

Subjects

Haematology

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

More from this journal

The newest in Journal of Blood & Lymph.

All its articles

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalJournal of Blood & Lymph
  • SubjectHaematology
  • BylineArticles whose byline prints “Alan Chew Bonilla”
  • BylineArticles whose byline prints “Emanuel Chew Bonilla”
  • BylineArticles whose byline prints “Paulina Bueno Zarazua”
  • BylineArticles whose byline prints “Federico Graue Wiechers”